2007 – KINETO Lab Ltd. founded by József Tóvári and Attila Kigyós

2010 – First own CD34 antibody developed

2015 – KINETO Lab Ltd. participating in Horizon 2020 Marie Skłodowska-Curie Actions “Magicbullet” consortium

2016 – The Company joined the Hungarian KRAS consortium (RASopathies)

2017 – Tumor endothelial stem cell research launched

2018 – KINETO Lab Ltd. participating in Horizon 2020 Marie Skłodowska-Curie Actions “Magicbullet::Reloaded” consortium

2019 – First PDTX models established, PDTX biobank launched

2020 – Our work on endothelial cells reinforced by the company’s first related PhD work